Session Chair: Andrés Cervantes, MD, PhD – Biomedical Research institute INCLIVA, University of Valencia, Hospital Clínico de Valencia
Session Chair: Deniz Can Güven, MD – Hacettepe University Cancer Institute
Session Chair: Rille Pihlak, MD, PhD – St Bart's Hospital
Session Chair: Andrés Cervantes, MD, PhD – Biomedical Research institute INCLIVA, University of Valencia, Hospital Clínico de Valencia
Session Chair: Deniz Can Güven, MD – Hacettepe University Cancer Institute
Session Chair: Rille Pihlak, MD, PhD – St Bart's Hospital
Session Chair: Andrés Cervantes, MD, PhD (he/him/his) – Biomedical Research institute INCLIVA, University of Valencia, Hospital Clínico de Valencia
### he/him/his @@@ Deniz Can Güven, MD – Hacettepe University Cancer Institute ### 1940200###Session Chair###Medical Oncologist###Hacettepe University Cancer Institute###Session Chair: Deniz Can Güven, MD – Hacettepe University Cancer Institute
### @@@ Rille Pihlak, MD, PhD (she/her/hers) – St Bart's Hospital ### 1293161###Session Chair###Consultant Medical Oncologist###St Bart's Hospital###Session Chair: Rille Pihlak, MD, PhD (she/her/hers) – St Bart's Hospital
### she/her/hersSpeaker: Sheela Rao, MBBS FRCP MD (Res ) – Royal Marsden Hospital
Speaker: Sheela Rao, MBBS FRCP MD (Res ) (she/her/hers) – Royal Marsden Hospital
### she/her/hersSpeaker: Michel P. Ducreux, MD, PhD – Gustave Roussy, Université Paris-Saclay
Speaker: Michel P. Ducreux, MD, PhD – Gustave Roussy, Université Paris-Saclay
###Moderator: Andrés Cervantes, MD, PhD – Biomedical Research institute INCLIVA, University of Valencia, Hospital Clínico de Valencia
Moderator: Deniz Can Güven, MD – Hacettepe University Cancer Institute
Moderator: Rille Pihlak, MD, PhD – St Bart's Hospital
Panelist: Michel P. Ducreux, MD, PhD – Gustave Roussy, Université Paris-Saclay
Panelist: Sheela Rao, MBBS FRCP MD (Res ) – Royal Marsden Hospital
Moderator: Andrés Cervantes, MD, PhD (he/him/his) – Biomedical Research institute INCLIVA, University of Valencia, Hospital Clínico de Valencia
### he/him/his @@@ Deniz Can Güven, MD – Hacettepe University Cancer Institute ### 1940200###Moderator###Medical Oncologist###Hacettepe University Cancer Institute###Moderator: Deniz Can Güven, MD – Hacettepe University Cancer Institute
### @@@ Rille Pihlak, MD, PhD (she/her/hers) – St Bart's Hospital ### 1293161###Moderator###Consultant Medical Oncologist###St Bart's Hospital###Moderator: Rille Pihlak, MD, PhD (she/her/hers) – St Bart's Hospital
### she/her/hers @@@ Michel P. Ducreux, MD, PhD – Gustave Roussy, Université Paris-Saclay ### 710546###Panelist###Head of Gastrointestinal Oncology Unit###Gustave Roussy, Université Paris-Saclay###Panelist: Michel P. Ducreux, MD, PhD – Gustave Roussy, Université Paris-Saclay
### @@@ Sheela Rao, MBBS FRCP MD (Res ) (she/her/hers) – Royal Marsden Hospital ### 1940204###Panelist###Consultant Medical Oncologist###Royal Marsden Hospital###Panelist: Sheela Rao, MBBS FRCP MD (Res ) (she/her/hers) – Royal Marsden Hospital
### she/her/hersSpeaker: Dirk Arnold, MD PhD – Asklepios Tumorzentrum Hamburg
Speaker: Dirk Arnold, MD PhD (he/him/his) – Asklepios Tumorzentrum Hamburg
### he/him/hisSpeaker: Myriam Chalabi, MD PhD – Netherlands Cancer Institute
Speaker: Myriam Chalabi, MD PhD – Netherlands Cancer Institute
###Moderator: Andrés Cervantes, MD, PhD – Biomedical Research institute INCLIVA, University of Valencia, Hospital Clínico de Valencia
Moderator: Deniz Can Güven, MD – Hacettepe University Cancer Institute
Moderator: Rille Pihlak, MD, PhD – St Bart's Hospital
Panelist: Dirk Arnold, MD PhD – Asklepios Tumorzentrum Hamburg
Panelist: Myriam Chalabi, MD PhD – Netherlands Cancer Institute
Moderator: Andrés Cervantes, MD, PhD (he/him/his) – Biomedical Research institute INCLIVA, University of Valencia, Hospital Clínico de Valencia
### he/him/his @@@ Deniz Can Güven, MD – Hacettepe University Cancer Institute ### 1940200###Moderator###Medical Oncologist###Hacettepe University Cancer Institute###Moderator: Deniz Can Güven, MD – Hacettepe University Cancer Institute
### @@@ Rille Pihlak, MD, PhD (she/her/hers) – St Bart's Hospital ### 1293161###Moderator###Consultant Medical Oncologist###St Bart's Hospital###Moderator: Rille Pihlak, MD, PhD (she/her/hers) – St Bart's Hospital
### she/her/hers @@@ Dirk Arnold, MD PhD (he/him/his) – Asklepios Tumorzentrum Hamburg ### 1320042###Panelist###Director###Asklepios Tumorzentrum Hamburg###Panelist: Dirk Arnold, MD PhD (he/him/his) – Asklepios Tumorzentrum Hamburg
### he/him/his @@@ Myriam Chalabi, MD PhD – Netherlands Cancer Institute ### 1560499###Panelist###Medical Oncologist, Clinical Group Leader###Netherlands Cancer Institute ###Panelist: Myriam Chalabi, MD PhD – Netherlands Cancer Institute
###Chair: Andrzej Deptala – Medical University of Warsaw
Chair: Gerald Prager, MD – Medizinische Universität Wien
Chair: Andrzej Deptala – Medical University of Warsaw
Chair: Gerald Prager, MD – Medizinische Universität Wien
Chair: Andrzej Deptala (he/him/his) – Medical University of Warsaw
### he/him/his @@@ Gerald Prager, MD – Medizinische Universität Wien ### 716608###Chair###Associate Professor###Medizinische Universität Wien###Chair: Gerald Prager, MD – Medizinische Universität Wien
###Abstract Presenter: James Harding
Abstract Presenter: James Harding
###Abstract Presenter: Maeve Lowery
Abstract Presenter: Maeve Lowery
###Abstract Presenter: Monica Niger
Abstract Presenter: Monica Niger
###Abstract Presenter: Leony Antoun
Abstract Presenter: Leony Antoun
###Abstract Presenter: Antoine Hollebecque
Abstract Presenter: Antoine Hollebecque
###Discussant: Teresa Macarulla, MD, PhD – Vall d’Hebrón University Hospital
Discussant: Teresa Macarulla, MD, PhD (she/her/hers) – Vall d’Hebrón University Hospital
### she/her/hersAbstract Presenter: Michael J. Pishvaian, MD, PhD – Johns Hopkins University
Abstract Presenter: Michael J. Pishvaian, MD, PhD – Johns Hopkins University
###Abstract Presenter: Lena Weiss
Abstract Presenter: Lena Weiss
###Abstract Presenter: Changhoon Yoo
Abstract Presenter: Changhoon Yoo
###Abstract Presenter: Jean-Baptiste Bachet
Abstract Presenter: Jean-Baptiste Bachet
###Discussant: Gerald Prager, MD – Medizinische Universität Wien
Discussant: Gerald Prager, MD – Medizinische Universität Wien
###Chair: Florian Lordick, MD, PhD – Leipzig University Medical Center
Chair: Anna D. Wagner, MD – Lausanne University Hospital, University of Lausanne
Chair: Florian Lordick, MD, PhD – Leipzig University Medical Center
Chair: Anna D. Wagner, MD – Lausanne University Hospital, University of Lausanne
Chair: Florian Lordick, MD, PhD (he/him/his) – Leipzig University Medical Center
### he/him/his @@@ Anna D. Wagner, MD – Lausanne University Hospital, University of Lausanne ### 716602###Chair###Senior lecturer and consultant, head upper GI unit###Lausanne University Hospital, University of Lausanne###Chair: Anna D. Wagner, MD – Lausanne University Hospital, University of Lausanne
###Abstract Presenter: Lucjan Wyrwicz, MD PhD – Maria Sklodowska-Curie National Cancer Research Institute
Abstract Presenter: Lucjan Wyrwicz, MD PhD (he/him/his) – Maria Sklodowska-Curie National Cancer Research Institute
### he/him/hisAbstract Presenter: Jin Li
Abstract Presenter: Jin Li
###Abstract Presenter: Taroh Satoh
Abstract Presenter: Taroh Satoh
###Discussant: Florian Lordick, MD, PhD – Leipzig University Medical Center
Discussant: Florian Lordick, MD, PhD (he/him/his) – Leipzig University Medical Center
### he/him/hisAbstract Presenter: Anna D. Wagner, MD – Lausanne University Hospital, University of Lausanne
Abstract Presenter: Anna D. Wagner, MD – Lausanne University Hospital, University of Lausanne
###Abstract Presenter: Maximilian Kloft
Abstract Presenter: Maximilian Kloft
###Abstract Presenter: Zev A. Wainberg, MD, Msc – UCLA School of Medicine
Abstract Presenter: Zev A. Wainberg, MD, Msc – UCLA School of Medicine
###Abstract Presenter: Antonella Cammarota
Abstract Presenter: Antonella Cammarota
###Discussant: Kohei Shitara, MD – National Cancer Center Hospital East
Discussant: Kohei Shitara, MD – National Cancer Center Hospital East
###Session Chair: Arndt Vogel, MD – Medizinische Hochschule Hannover
Session Chair: Arndt Vogel, MD – Medizinische Hochschule Hannover
Session Chair: Arndt Vogel, MD – Medizinische Hochschule Hannover
###Panelist: Maria Reig, MD, PhD – Hospital Clinic Barcelona
Panelist: Lorenza Rimassa, MD – Humanitas University and IRCCS Humanitas Research Hospital
Panelist: Chris J. Verslype, MD PhD – University Hospitals Leuven / KU Leuven
Panelist: Maria Reig, MD, PhD – Hospital Clinic Barcelona
### @@@ Lorenza Rimassa, MD (she/her/hers) – Humanitas University and IRCCS Humanitas Research Hospital ### 1666115###Panelist###Associate Professor of Medical Oncology###Humanitas University and IRCCS Humanitas Research Hospital###Panelist: Lorenza Rimassa, MD (she/her/hers) – Humanitas University and IRCCS Humanitas Research Hospital
### she/her/hers @@@ Chris J. Verslype, MD PhD – University Hospitals Leuven / KU Leuven ### 716620###Panelist###Professor###University Hospitals Leuven / KU Leuven###Panelist: Chris J. Verslype, MD PhD – University Hospitals Leuven / KU Leuven
###Poster Discussant: Fatima Carneiro, MD, PhD – Institute of Pathology and Molecular Immunology of the University of Porto (IPATIMUP)
Poster Discussant: Fatima Carneiro, MD, PhD – Institute of Pathology and Molecular Immunology of the University of Porto (IPATIMUP)
###Poster Discussant: Elizabeth C. Smyth, MD – Oxford Cancer, United Kingdom
Poster Discussant: Elizabeth C. Smyth, MD – Oxford Cancer, United Kingdom
###Poster Discussant: Radka Obermannova, MD, PhD – Masaryk Memorial Cancer Institute and Masaryk University
Poster Discussant: Radka Obermannova, MD, PhD – Masaryk Memorial Cancer Institute and Masaryk University
###Chair: Sara De Dosso, MD – Medical Oncology Department, Oncology Institute of Southern Switzerland
Chair: Kohei Shitara, MD – National Cancer Center Hospital East
Chair: Sara De Dosso, MD – Medical Oncology Department, Oncology Institute of Southern Switzerland
Chair: Kohei Shitara, MD – National Cancer Center Hospital East
Chair: Sara De Dosso, MD – Medical Oncology Department, Oncology Institute of Southern Switzerland
### @@@ Kohei Shitara, MD – National Cancer Center Hospital East ### 716598###Chair###Director###National Cancer Center Hospital East###Chair: Kohei Shitara, MD – National Cancer Center Hospital East
###Speaker: Hanneke Van Laarhoven, MD, PhD – Amsterdam UMC
Speaker: Hanneke Van Laarhoven, MD, PhD – Amsterdam UMC
###Abstract Presenter: Elizabeth C. Smyth, MD – Oxford Cancer, United Kingdom
Abstract Presenter: Elizabeth C. Smyth, MD – Oxford Cancer, United Kingdom
###Abstract Presenter: Ronan Kelly
Abstract Presenter: Ronan Kelly
###Speaker: Salah-Eddin Al-Batran, Prof. Dr. – Krankenhaus Nordwest, Frankfurt
Speaker: Salah-Eddin Al-Batran, Prof. Dr. (he/him/his) – Krankenhaus Nordwest, Frankfurt
### he/him/hisSpeaker: Patrick Tan, MD. PhD – Duke-NUS Medical School
Speaker: Patrick Tan, MD. PhD (he/him/his) – Duke-NUS Medical School
### he/him/hisAbstract Presenter: Giovanni Randon
Abstract Presenter: Giovanni Randon
###Speaker: Filippo Pietrantonio, Dr – Fondazione IRCCS Istituto Nazionale dei Tumori
Speaker: Filippo Pietrantonio, Dr (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori
### he/him/hisSpeaker: Markus Moehler, MD – Universitätsmedizin Mainz
Speaker: Markus Moehler, MD (he/him/his) – Universitätsmedizin Mainz
### he/him/hisSpeaker: Elizabeth C. Smyth, MD – Oxford Cancer, United Kingdom
Speaker: Elizabeth C. Smyth, MD – Oxford Cancer, United Kingdom
###Speaker: Kohei Shitara, MD – National Cancer Center Hospital East
Speaker: Kohei Shitara, MD – National Cancer Center Hospital East
###Moderator: Sara De Dosso, MD – Medical Oncology Department, Oncology Institute of Southern Switzerland
Moderator: Kohei Shitara, MD – National Cancer Center Hospital East
Panelist: Salah-Eddin Al-Batran, Prof. Dr. – Krankenhaus Nordwest, Frankfurt
Panelist: Markus Moehler, MD – Universitätsmedizin Mainz
Panelist: Filippo Pietrantonio, Dr – Fondazione IRCCS Istituto Nazionale dei Tumori
Panelist: Elizabeth C. Smyth, MD – Oxford Cancer, United Kingdom
Panelist: Patrick Tan, MD. PhD – Duke-NUS Medical School
Panelist: Hanneke Van Laarhoven, MD, PhD – Amsterdam UMC
Moderator: Sara De Dosso, MD – Medical Oncology Department, Oncology Institute of Southern Switzerland
### @@@ Kohei Shitara, MD – National Cancer Center Hospital East ### 716598###Moderator###Director###National Cancer Center Hospital East###Moderator: Kohei Shitara, MD – National Cancer Center Hospital East
### @@@ Salah-Eddin Al-Batran, Prof. Dr. (he/him/his) – Krankenhaus Nordwest, Frankfurt ### 1560486###Panelist###Medical Director###Krankenhaus Nordwest, Frankfurt###Panelist: Salah-Eddin Al-Batran, Prof. Dr. (he/him/his) – Krankenhaus Nordwest, Frankfurt
### he/him/his @@@ Markus Moehler, MD (he/him/his) – Universitätsmedizin Mainz ### 983893###Panelist###Consultant###Universitätsmedizin Mainz###Panelist: Markus Moehler, MD (he/him/his) – Universitätsmedizin Mainz
### he/him/his @@@ Filippo Pietrantonio, Dr (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori ### 1919816###Panelist###MD###Fondazione IRCCS Istituto Nazionale dei Tumori###Panelist: Filippo Pietrantonio, Dr (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori
### he/him/his @@@ Elizabeth C. Smyth, MD – Oxford Cancer, United Kingdom ### 716617###Panelist###Consultant Oncologist###Oxford Cancer, United Kingdom###Panelist: Elizabeth C. Smyth, MD – Oxford Cancer, United Kingdom
### @@@ Patrick Tan, MD. PhD (he/him/his) – Duke-NUS Medical School ### 1919813###Panelist###Professor###Duke-NUS Medical School###Panelist: Patrick Tan, MD. PhD (he/him/his) – Duke-NUS Medical School
### he/him/his @@@ Hanneke Van Laarhoven, MD, PhD – Amsterdam UMC ### 1919811###Panelist###Head of the Department of Medical Oncology###Amsterdam UMC###Panelist: Hanneke Van Laarhoven, MD, PhD – Amsterdam UMC
###Chair: Michel P. Ducreux, MD, PhD – Gustave Roussy, Université Paris-Saclay
Chair: Angela Lamarca, MD, PhD – Fundacion Jimenez Diaz University Hospital
Chair: Michel P. Ducreux, MD, PhD – Gustave Roussy, Université Paris-Saclay
Chair: Angela Lamarca, MD, PhD – Fundacion Jimenez Diaz University Hospital
Chair: Michel P. Ducreux, MD, PhD – Gustave Roussy, Université Paris-Saclay
### @@@ Angela Lamarca, MD, PhD – Fundacion Jimenez Diaz University Hospital ### 1252920###Chair###Consultant Medical Oncologist###Fundacion Jimenez Diaz University Hospital###Chair: Angela Lamarca, MD, PhD – Fundacion Jimenez Diaz University Hospital
###Speaker: Jessica Zucman-Rossi, MD, PhD – Université Paris Cité
Speaker: Jessica Zucman-Rossi, MD, PhD (she/her/hers) – Université Paris Cité
### she/her/hersSpeaker: Jordi Rimola, MD PhD – Hospital Clínic Barcelona
Speaker: Jordi Rimola, MD PhD (he/him/his) – Hospital Clínic Barcelona
### he/him/hisAbstract Presenter: Arndt Vogel, MD – Medizinische Hochschule Hannover
Abstract Presenter: Arndt Vogel, MD – Medizinische Hochschule Hannover
###Abstract Presenter: Bruno Sangro, MD, PhD – Clinica Universidad de Navarra
Abstract Presenter: Bruno Sangro, MD, PhD – Clinica Universidad de Navarra
###Abstract Presenter: Sang Hoon Seo
Abstract Presenter: Sang Hoon Seo
###Discussant: Angela Lamarca, MD, PhD – Fundacion Jimenez Diaz University Hospital
Discussant: Angela Lamarca, MD, PhD – Fundacion Jimenez Diaz University Hospital
###Speaker: Ghassan K. Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center
Speaker: Ghassan K. Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center
###Speaker: Lorenza Rimassa, MD – Humanitas University and IRCCS Humanitas Research Hospital
Speaker: Lorenza Rimassa, MD (she/her/hers) – Humanitas University and IRCCS Humanitas Research Hospital
### she/her/hersModerator: Angela Lamarca, MD, PhD – Fundacion Jimenez Diaz University Hospital
Moderator: Lorenza Rimassa, MD – Humanitas University and IRCCS Humanitas Research Hospital
Panelist: Arndt Vogel, MD – Medizinische Hochschule Hannover
Panelist: Ghassan K. Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center
Panelist: Chris J. Verslype, MD PhD – University Hospitals Leuven / KU Leuven
Panelist: Jordi Rimola, MD PhD – Hospital Clínic Barcelona
Moderator: Angela Lamarca, MD, PhD – Fundacion Jimenez Diaz University Hospital
### @@@ Lorenza Rimassa, MD (she/her/hers) – Humanitas University and IRCCS Humanitas Research Hospital ### 1666115###Moderator###Associate Professor of Medical Oncology###Humanitas University and IRCCS Humanitas Research Hospital###Moderator: Lorenza Rimassa, MD (she/her/hers) – Humanitas University and IRCCS Humanitas Research Hospital
### she/her/hers @@@ Arndt Vogel, MD – Medizinische Hochschule Hannover ### 716621###Panelist###Senior Consultant###Medizinische Hochschule Hannover###Panelist: Arndt Vogel, MD – Medizinische Hochschule Hannover
### @@@ Ghassan K. Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center ### 697827###Panelist###Professor###Memorial Sloan Kettering Cancer Center###Panelist: Ghassan K. Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center
### @@@ Chris J. Verslype, MD PhD – University Hospitals Leuven / KU Leuven ### 716620###Panelist###Professor###University Hospitals Leuven / KU Leuven###Panelist: Chris J. Verslype, MD PhD – University Hospitals Leuven / KU Leuven
### @@@ Jordi Rimola, MD PhD (he/him/his) – Hospital Clínic Barcelona ### 1968790###Panelist###Consultant###Hospital Clínic Barcelona###Panelist: Jordi Rimola, MD PhD (he/him/his) – Hospital Clínic Barcelona
### he/him/hisPoster Discussant: Teresa Macarulla, MD, PhD – Vall d’Hebrón University Hospital
Poster Discussant: Teresa Macarulla, MD, PhD (she/her/hers) – Vall d’Hebrón University Hospital
### she/her/hersPoster Discussant: Ghassan K. Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center
Poster Discussant: Ghassan K. Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center
###Poster Discussant: Angela Lamarca, MD, PhD – Fundacion Jimenez Diaz University Hospital
Poster Discussant: Angela Lamarca, MD, PhD – Fundacion Jimenez Diaz University Hospital
###Session Chair: Deniz Can Güven, MD – Hacettepe University Cancer Institute
Session Chair: Rille Pihlak, MD, PhD – St Bart's Hospital
Session Chair: Deniz Can Güven, MD – Hacettepe University Cancer Institute
Session Chair: Rille Pihlak, MD, PhD – St Bart's Hospital
Session Chair: Deniz Can Güven, MD – Hacettepe University Cancer Institute
### @@@ Rille Pihlak, MD, PhD (she/her/hers) – St Bart's Hospital ### 1293161###Session Chair###Consultant Medical Oncologist###St Bart's Hospital###Session Chair: Rille Pihlak, MD, PhD (she/her/hers) – St Bart's Hospital
### she/her/hersSpeaker: Jayne Wood, Dr – The Royal Marsden NHS Foundation Trust
Speaker: Jayne Wood, Dr (she/her/hers) – The Royal Marsden NHS Foundation Trust
### she/her/hersSpeaker: Florian Scotte – Gustave Roussy
Speaker: Florian Scotte – Gustave Roussy
###Session Chair: Deniz Can Güven, MD – Hacettepe University Cancer Institute
Session Chair: Rille Pihlak, MD, PhD – St Bart's Hospital
Panelist: Florian Scotte – Gustave Roussy
Panelist: Jayne Wood, Dr – The Royal Marsden NHS Foundation Trust
Session Chair: Deniz Can Güven, MD – Hacettepe University Cancer Institute
### @@@ Rille Pihlak, MD, PhD (she/her/hers) – St Bart's Hospital ### 1293161###Session Chair###Consultant Medical Oncologist###St Bart's Hospital###Session Chair: Rille Pihlak, MD, PhD (she/her/hers) – St Bart's Hospital
### she/her/hers @@@ Florian Scotte – Gustave Roussy ### 1940218###Panelist###Head of division###Gustave Roussy###Panelist: Florian Scotte – Gustave Roussy
### @@@ Jayne Wood, Dr (she/her/hers) – The Royal Marsden NHS Foundation Trust ### 1970653###Panelist###Consultant Palliative Medicine###The Royal Marsden NHS Foundation Trust###Panelist: Jayne Wood, Dr (she/her/hers) – The Royal Marsden NHS Foundation Trust
### she/her/hersChair: Eric Van Cutsem, MD, PhD – University Hospitals Leuven / KU Leuven
Chair: Josep Tabernero, MD – Vall d’Hebron University Hospital
Chair: Michel P. Ducreux, MD, PhD – Gustave Roussy, Université Paris-Saclay
Chair: Eric Van Cutsem, MD, PhD – University Hospitals Leuven / KU Leuven
Chair: Josep Tabernero, MD – Vall d’Hebron University Hospital
Chair: Michel P. Ducreux, MD, PhD – Gustave Roussy, Université Paris-Saclay
Chair: Eric Van Cutsem, MD, PhD (he/him/his) – University Hospitals Leuven / KU Leuven
### he/him/his @@@ Josep Tabernero, MD (he/him/his) – Vall d’Hebron University Hospital ### 710542###Chair###Head, Medical Oncology Department###Vall d’Hebron University Hospital###Chair: Josep Tabernero, MD (he/him/his) – Vall d’Hebron University Hospital
### he/him/his @@@ Michel P. Ducreux, MD, PhD – Gustave Roussy, Université Paris-Saclay ### 710546###Chair###Head of Gastrointestinal Oncology Unit###Gustave Roussy, Université Paris-Saclay###Chair: Michel P. Ducreux, MD, PhD – Gustave Roussy, Université Paris-Saclay
###Speaker: Jerome Galon, PhD – INSERM
Speaker: Jerome Galon, PhD – INSERM
###Moderator: Eric Van Cutsem, MD, PhD – University Hospitals Leuven / KU Leuven
Moderator: Josep Tabernero, MD – Vall d’Hebron University Hospital
Moderator: Michel P. Ducreux, MD, PhD – Gustave Roussy, Université Paris-Saclay
Panelist: Jerome Galon, PhD – INSERM
Moderator: Eric Van Cutsem, MD, PhD (he/him/his) – University Hospitals Leuven / KU Leuven
### he/him/his @@@ Josep Tabernero, MD (he/him/his) – Vall d’Hebron University Hospital ### 710542###Moderator###Head, Medical Oncology Department###Vall d’Hebron University Hospital###Moderator: Josep Tabernero, MD (he/him/his) – Vall d’Hebron University Hospital
### he/him/his @@@ Michel P. Ducreux, MD, PhD – Gustave Roussy, Université Paris-Saclay ### 710546###Moderator###Head of Gastrointestinal Oncology Unit###Gustave Roussy, Université Paris-Saclay###Moderator: Michel P. Ducreux, MD, PhD – Gustave Roussy, Université Paris-Saclay
### @@@ Jerome Galon, PhD – INSERM ### 1560502###Panelist###Director###INSERM###Panelist: Jerome Galon, PhD – INSERM
###